Home » Topics » BioWorld Science

BioWorld Science
RSS

BCMA CAR-T cells engineered with membrane-bound IL-15 show increased in vivo activity

July 6, 2021

Antitumor activity of luxeptinib described in phase Ia/b study in B-cell malignancies

July 6, 2021

Vaccinia virus-expressed SARS-CoV-2 spike protein promotes cellular and humoral immunity in mice

July 6, 2021

Novel tau tubulin kinase 1 inhibitors reduce tau phosphorylation in vivo

July 6, 2021

Venadaparib shows safety and preliminary efficacy in first-in-human trial

July 6, 2021

Mersana starts phase I/II umbrella study of XMT-1536 in high-grade serous ovarian cancer

July 6, 2021

Enrollment ongoing in phase I/II study of PVSRIPO

July 6, 2021

DPP3 is a marker of severity in heart failure

July 5, 2021

Transcenta reports antitumor responses with TST-001 in gastric cancer

July 5, 2021

Initiation of phase II study of HA-121-28 in advanced biliary tract cancer

July 5, 2021

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...